What is the current Merck KGaA market capitalization?
The current market capitalization of Merck KGaA is 66.24 B EUR.
Merck KGaA Market capitalization 2024
Merck KGaA Market capitalization
66.24 B EUR
Merck KGaA Dividend yield
1.44 %
Ticker
MRK.DE
ISIN
DE0006599905
WKN
659990
In 2024, Merck KGaA's market cap stood at 66.24 B EUR, a -6.51% increase from the 70.85 B EUR market cap in the previous year.
The Merck KGaA Market capitalization history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) | NET INCOME (undefined EUR) |
|---|---|---|---|
| 2029e | 29.65 | 42,57 | - |
| 2028e | 26.86 | 46,99 | 1.52 |
| 2027e | 25.81 | 48,91 | 1.53 |
| 2026e | 23.74 | 53,17 | 1.39 |
| 2025e | 22.78 | 55,41 | 1.28 |
| 2024e | 21.53 | 58,64 | 1.12 |
| 2023 | 20.99 | 60,13 | 2.82 |
| 2022 | 22.23 | 62,16 | 3.33 |
| 2021 | 19.69 | 62,79 | 3.06 |
| 2020 | 17.53 | 61,32 | 1.99 |
| 2019 | 16.15 | 63,16 | 1.32 |
| 2018 | 14.84 | 63,99 | 3.37 |
| 2017 | 14.52 | 65,07 | 2.61 |
| 2016 | 15.02 | 65,38 | 1.63 |
| 2015 | 12.84 | 68,26 | 1.11 |
| 2014 | 11.36 | 68,97 | 1.16 |
| 2013 | 11.1 | 73,03 | 1.2 |
| 2012 | 11.17 | 71,74 | 0.57 |
| 2011 | 10.28 | 72,87 | 0.62 |
| 2010 | 9.29 | 74,32 | 0.63 |
| 2009 | 7.75 | 73,81 | 0.37 |
| 2008 | 7.56 | 74,78 | 0.37 |
| 2007 | 7.06 | 74,78 | 3.5 |
| 2006 | 6.28 | 61,58 | 0.98 |
| 2005 | 5.97 | 60,30 | 0.66 |
| 2004 | 5.47 | 58,91 | 0.66 |
Merck KGaA Aktienanalyse
What does Merck KGaA do?
Merck is one of the oldest and most well-known companies in the pharmaceutical and chemical industry. It was founded as a pharmacy in Darmstadt in 1668 and has since developed into a global company that is successful worldwide. Merck's business model is based on various business areas, all of which are based on scientific research and innovation. The three main business areas are the Life Science, Healthcare, and Performance Materials divisions, all of which focus on providing products and services for a wide range of industries. Life Science is Merck's largest business area, focusing on providing materials, products, instruments, and services for scientific research and biopharmaceutical production. The company offers a wide range of products that focus on the work of researchers and scientists in molecular biology, cell technology, and genomics. Healthcare is another important business area for Merck, focusing on the manufacture and marketing of innovative drugs and treatments for patients. The company offers products for the treatment of diseases such as cancer, multiple sclerosis, and schizophrenia. Performance Materials is Merck's third business area, specializing in the production of materials and technologies for various industries such as the automotive industry, electronics, and packaging. The company focuses on the development of innovative materials such as liquid crystals and organic photovoltaic materials. Merck is also known for its research and development, and the company invests significant resources in developing new products and technologies. This is also evident in the extensive portfolio of products offered by Merck. The company offers a wide range of products ranging from laboratory and analysis equipment to pharmaceuticals and biopharmaceuticals to specialty chemicals. An example of an important product from Merck is the rheumatoid arthritis drug Remicade, which was developed in collaboration with Johnson & Johnson. Merck is also one of the leading manufacturers of liquid crystals for use in displays and electronic devices. Merck is a company committed to social responsibility and sustainability. The company is involved in many areas, including environmental, social, and governance issues. Merck is committed to developing sustainable products and technologies and is dedicated to promoting education, health, and social justice in the communities where it operates. Overall, Merck is a leading company in the pharmaceutical and chemical industry, known for its innovation, research and development, as well as its social responsibility and sustainability. With currently approximately 58,000 employees and annual sales of 17.4 billion euros, the global company network is represented in 67 countries and demonstrates the quality and capabilities of the company worldwide. Merck KGaA ist eines der beliebtesten Unternehmen auf Eulerpool.com.Merck KGaA revenue by segment
In the annual report of the Merck KGaA share (DE0006599905, 659990, MRK.DE), it breaks down its revenues into 3 segments: 1. Life Science, 2. Healthcare, 3. Performance Materials. The Merck KGaA stock (WKN: 659990, ISIN: DE0006599905, Ticker Symbol: MRK.DE) is a leading investment for investors interested in participating in the Health Care sector.
Market capitalization Details
Exploring Merck KGaA's Market Capitalization
Merck KGaA's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Merck KGaA's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Merck KGaA's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Merck KGaA’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Merck KGaA Stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Merck KGaA.
How has the market capitalization of Merck KGaA developed in recent years?
The market capitalization of Merck KGaA has increased/decreased by -6.51% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Merck KGaA?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Merck KGaA?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Merck KGaA have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Merck KGaA pay?
Over the past 12 months, Merck KGaA paid a dividend of 2.2 EUR . This corresponds to a dividend yield of about 1.44 %. For the coming 12 months, Merck KGaA is expected to pay a dividend of 2.42 EUR.
What is the dividend yield of Merck KGaA?
The current dividend yield of Merck KGaA is 1.44 %.
When does Merck KGaA pay dividends?
Merck KGaA pays a quarterly dividend. This is distributed in the months of May, May, June, May.
How secure is the dividend of Merck KGaA?
Merck KGaA paid dividends every year for the past 0 years.
What is the dividend of Merck KGaA?
For the upcoming 12 months, dividends amounting to 2.42 EUR are expected. This corresponds to a dividend yield of 1.59 %.
In which sector is Merck KGaA located?
Merck KGaA is assigned to the 'Health' sector.
Wann musste ich die Aktien von Merck KGaA kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Merck KGaA from 5/2/2024 amounting to 2.2 EUR, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.
When did Merck KGaA pay the last dividend?
The last dividend was paid out on 5/2/2024.
What was the dividend of Merck KGaA in the year 2023?
In the year 2023, Merck KGaA distributed 1.85 EUR as dividends.
In which currency does Merck KGaA pay out the dividend?
The dividends of Merck KGaA are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Merck KGaA stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank
Andere Kennzahlen von Merck KGaA
Our stock analysis for Merck KGaA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merck KGaA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
